From the Department of Pathology, UH Cleveland Medical Center, Cleveland, Ohio (Hou).
the Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Yang, Zhang).
Arch Pathol Lab Med. 2022 Jan 2;146(2):166-171. doi: 10.5858/arpa.2020-0432-OA.
CONTEXT.—: Female adnexal tumor of probable Wolffian origin (FATWO) often is a diagnostic challenge given its rarity, histologic heterogeneity, and lack of specific immunoprofile.
OBJECTIVE.—: To further understand the clinicopathologic and immunohistochemical features of this rare entity.
DESIGN.—: We studied the clinical, morphologic, and immunohistochemical features of a cohort of 11 FATWO cases from our institute.
RESULTS.—: Patients' age ranged from 25 to 76 years (mean, 55 years). Tumor size ranged from 0.5 to 18 cm (mean, 2.7 cm). Histopathologically, most tumors presented with low-grade cytologic features with low mitotic activity and lack of necrosis. Three main growth patterns were appreciated: solid, tubular, and sievelike patterns. Higher-grade nuclear atypia, increased mitotic activity, and focal necrosis were seen in 2 cases. These 2 cases were clinically considered malignant FATWO mainly because of their extra-adnexal involvement. Immunohistochemical studies found that tumor cells were positive for CD10 (11 of 11, 100%), AE1/3 (8 of 8, 100%), CAM 5.2 (4 of 5, 80%), and cytokeratin 7 (CK7; 7 of 10, 70%), and focally positive for calretinin (4 of 10, 40%), inhibin (4 of 10, 40%), epithelial membrane antigen (EMA; 3 of 9, 33%), and steroidogenic factor-1 (SF-1; 2 of 8, 25%). Lack of immunoreactivity to PAX8 and GATA3 in almost all cases indicates that FATWO is different from the tumors derived from the Müllerian or mesonephric origins. All patients with available follow-up had favorable prognosis.
CONCLUSION.—: The broad spectrum of clinical presentation, various morphologic features, and overlapping immunophenotype suggest that FATWO is a diagnosis of exclusion until it is further defined at the molecular and immunohistochemical levels.
由于其罕见性、组织学异质性和缺乏特异性免疫表型,女性附件肿瘤的可能沃夫氏来源(FATWO)常常是一个诊断挑战。
进一步了解这种罕见实体的临床病理和免疫组织化学特征。
我们研究了来自我们研究所的 11 例 FATWO 病例的临床、形态学和免疫组织化学特征。
患者年龄为 25 岁至 76 岁(平均 55 岁)。肿瘤大小从 0.5 厘米至 18 厘米不等(平均 2.7 厘米)。组织病理学上,大多数肿瘤呈现出低级别细胞学特征,有低有丝分裂活性且无坏死。观察到 3 种主要的生长模式:实性、管状和筛状模式。在 2 例中观察到高级别核异型性、有丝分裂活性增加和局灶性坏死。这 2 例主要因为其附件外累及而被临床诊断为恶性 FATWO。免疫组织化学研究发现肿瘤细胞对 CD10(11/11,100%)、AE1/3(8/8,100%)、CAM5.2(4/5,80%)和细胞角蛋白 7(CK7;10/7,70%)呈阳性,局灶性对钙视网膜蛋白(4/10,40%)、抑制素(4/10,40%)、上皮膜抗原(EMA;9/3,33%)和类固醇生成因子-1(SF-1;8/2,25%)呈阳性。几乎所有病例的 PAX8 和 GATA3 免疫反应缺失表明,FATWO 与来源于 Müllerian 或中肾起源的肿瘤不同。所有有可用随访的患者均预后良好。
广泛的临床表现、各种形态学特征和重叠的免疫表型表明,直到在分子和免疫组织化学水平进一步定义之前,FATWO 是一个排除性诊断。